Table 2 Cytokine and lipid mediator analysis
From: Acute coronary syndrome and acute kidney injury: role of inflammation in worsening renal function
ACS | ACS + AKI | p | |
|---|---|---|---|
LTB4 pg/mL | 1630.04 (1114.72–1968.61) | 1711.674 (1092.63–1998.27) | 0.751 |
RvD1 ng/mL | 79.02 (78.38–79.87) | 79.68 (78.38–80.6) | 0.133 |
LxA4 pg/mL | 8.1 (5.91–9.0) | 7.23 (4.18–8.59) | 0.167 |
ET-1 pg/mL | 59.82 (40.27–80.36) | 70.58 (33.43–121.42) | 0.435 |
MMP-2 pg/mL | 2497.28 (2033.53–3100.16) | 2056.72 (1871.22–2705.97) | 0.068 |
MMP-9 pg/mL | 4615.7 (3103.64–5179.12) | 5375.66 (3737.82–6030.8) | 0.107 |
TIMP-1 pg/mL | 548.93 (420.28–749.69) | 544.25 (393.57–647.08) | 0.428 |
IL-1β pg/mL | 68.13 (0.55–242.91) | 400.1 (114.01–836.05) | 0.009 |
IL-6 pg/mL | 2399.67 (928.71–11,629.24) | 10,225.0 (1478.48–15,698.29) | 0.2 |
IL-8 pg/mL | 823.52 (513.57–1356.21) | 958.45 (620.41–2292.41) | 0.425 |
IL-10 pg/mL | 743.27 (206.63–1390.77) | 338.99 (197.90–24,162.37) | 0.929 |